# Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial

> **NCT06759753** · PHASE2 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 192 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Aleeto
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06759753
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-21
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-01-31
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06759753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06759753, "Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06759753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*